More than six years ago, the endTB trial started to transform MDR-TB treatments, which were long, ineffective and had terrible side effects. The study was performed to identify radically shorter, more tolerable, and injection-free treatments for MDR-TB. The endTB trial is offering a much-needed shot in the arm of the national programmes and policies by generating evidence of immense good quality. We were able to achieve successful results in treating every patient. endTB has been an excellent opportunity to demonstrate the efficacy and safety of shortened oral regimens in the fight against tuberculosis. This trial is a game-changer. We actually look forward to seeing the improvement that will come to the lives of our patients by using the endTB clinical trial regime

More on This

Tuberculosis Response Recovering From Covid-19 Pandemic - Report

• TB Response Recovering From Pandemic but Accelerated Efforts Needed to Meet New Targets - WHO
• More Action Needed to Write 'Final Chapter' of TB
• Like Covid-19, TB Is a Pandemic and Must Be Treated As an Emergency
• MSF Implores Govts to Use Recent TB Wins to Beat Back Deadly Infectious Disease

TB Ran Rampant During Covid-19 Pandemic - WHO

• Tuberculosis Deaths and Disease Increase During the Covid-19 Pandemic
• ACT-Accelerator Launches Six Month Plan As World Transitions to Long-Term Covid-19 Control
• Statement of the Thirty-Third Polio IHR Emergency Committee
• Third Meeting of the International Health Regulations (2005) (IHR) Emergency Committee Regarding the Multi-Country Outbreak of Monkeypox
• WHO Launches 4th Health for All Film Festival

Covid-19 Vaccination Roll-Out Stagnates in Africa - WHO

• Covid-19 Vaccination Roll-Out Stagnates in Africa
• No Time for Covid-19 Complacency, Say Key Countries Responsible for Tracking Global Rollout of Covid-19 Vaccines, Tests and Treatments
• Interim Statement On Covid-19 Vaccination for Children

WHO Wants More Investment for TB Treatment - Study Shows Why

• WHO Study Shows $39 Return for Each Dollar Invested in Fight Against TB
• WHO Urges Investments for the Scale Up of Tuberculosis Screening and Preventive Treatment
• Bill & Melinda Gates Medical Research Institute Initiates Phase Three Clinical Trial of Tuberculosis Vaccine Candidate
• UZ Launches Research Into Drug-Resistant TB
• Tuberculosis - MSF Launches Unprecedented Project to Tackle Underdiagnosis Among Children
• Survivors Lead Fight Against TB
• Health Ministry Launches Program to Help Fight TB By 2030